Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

INSM
Insmed, Inc.
stock NASDAQ

At Close
Sep 4, 2026 3:59:56 PM EDT
126.19USD-0.387%(-0.49)1,802,693
0.00Bid   0.00Ask   0.00Spread
Pre-market
Sep 4, 2026 9:27:30 AM EDT
126.20USD-0.379%(-0.48)1,141
After-hours
Sep 4, 2026 4:00:30 PM EDT
126.29USD+0.079%(+0.10)412,190
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
08:01AM EST  Call and Provide a Business and Pipeline Update on Thursday, February 17, 2022   PR Newswire
Jan 4, 2022
08:01AM EST  Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference   PR Newswire
Dec 6, 2021
10:05AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021   Benzinga
08:01AM EST  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
06:08AM EST  JP Morgan Initiates Coverage On Insmed with Overweight Rating, Announces Price Target of $45   Benzinga
Nov 5, 2021
08:01AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Nov 3, 2021
05:24PM EDT  Insmed Director Steinar Engelsen Reported Purchase of 14,235 Shares @ Avg Price of $30.14/Share in Form 4 Filing   Benzinga
08:01AM EDT  Insmed To Participate in Three November Conferences   PR Newswire
Oct 29, 2021
11:00AM EDT  Insmed Earnings Perspective: Return On Capital Employed   Benzinga
Oct 28, 2021
04:06PM EDT  Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List   PR Newswire
07:40AM EDT  Insmed Q3 Total Revenue $46.8 Mln Vs. $43.6 Mln Prior Year   RTTNews
07:31AM EDT  Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update   PR Newswire
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 25, 2021
11:25AM EDT  Insmed Incorporated Study Titled 'A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting   Benzinga
Oct 14, 2021
08:01AM EDT  Insmed to Host Third Quarter 2021 Financial Results Conference Call on   PR Newswire
Oct 8, 2021
11:52AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021   Benzinga
07:04AM EDT  Cantor Fitzgerald Initiates Coverage On Insmed with Overweight Rating, Announces Price Target of $60   Benzinga
Oct 5, 2021
08:08AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   RTTNews
Sep 1, 2021
08:01AM EDT  Insmed To Participate in Five September Conferences   PR Newswire
Aug 27, 2021
05:14PM EDT  Return on Capital Employed Insights for Insmed   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 6, 2021
08:02AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   RTTNews
Aug 5, 2021
08:04AM EDT  Insmed Q2 EPS $(1.07) Misses $(0.85) Estimate, Sales $45.40M Beat $43.72M Estimate   Benzinga
07:43AM EDT  Insmed Q2 Total Revenue $45.4 Mln Vs. $42.5 Mln Prior Year   RTTNews
07:31AM EDT  Insmed Reports Second Quarter 2021 Financial Results and Provides Business   PR Newswire
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 27, 2021
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
Jul 8, 2021
08:07AM EDT  Insmed Announces Granting Of Inducement Awards To 12 New Employees   RTTNews
08:02AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
May 25, 2021
07:01AM EDT  Insmed To Present at Two June Conferences   PR Newswire
May 19, 2021
04:06PM EDT  Insmed Presents Broad Range of Data Across Its Three Programs at the American   PR Newswire
May 13, 2021
11:15AM EDT  Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes   PR Newswire
May 11, 2021
02:59AM EDT  Insmed Prices Public Offering Of 10 Mln Shares At $25/Shr And Convertible Senior Notes Due 2028   RTTNews
01:54AM EDT  Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and   PR Newswire
May 10, 2021
02:40PM EDT  Mid-Afternoon Market Update: Dow Surges 125 Points; Trade Desk Shares Plunge   Benzinga
12:15PM EDT  Mid-Day Market Update: Nasdaq Drops 200 Points; Soliton Shares Spike Higher   Benzinga
10:30AM EDT  Mid-Morning Market Update: Markets Mixed; Tyson Foods Tops Q2 Views   Benzinga
09:18AM EDT  Morgan Stanley Maintains Overweight on Insmed, Lowers Price Target to $56   Benzinga
07:17AM EDT  Insmed Announces Proposed Concurrent Public Offerings Of $250M Of Common Stock And $500M Convertible Senior Notes Due 2028   Benzinga
07:03AM EDT  Insmed To Sell $250 Mln Of Its Common Stock   RTTNews
07:01AM EDT  Insmed Announces Proposed Concurrent Public Offerings of Common Stock and   PR Newswire
May 7, 2021
08:01AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
May 6, 2021
12:00PM EDT  Insmed shares were trading lower after the company reported worse-than-expected Q1 EPS and sales results.   Benzinga
08:41AM EDT  Insmed Q1 EPS $(0.89) Misses $(0.88) Estimate, Sales $40.21M Miss $41.64M Estimate   Benzinga
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
07:31AM EDT  Insmed Reports First Quarter 2021 Financial Results and Provides Business Update   PR Newswire
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
Apr 22, 2021
08:01AM EDT  Insmed to Host First Quarter 2021 Financial Results Conference Call on   PR Newswire
Apr 7, 2021
08:01AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Mar 23, 2021
08:18AM EDT  The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO   Benzinga
05:25AM EDT  Insmed: ARIKAYCE Approved In Japan NTM Lung Disease Caused By MAC Who Did Not Respond To Prior Care With MDR   RTTNews
05:01AM EDT  Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR   PR Newswire
Mar 5, 2021
08:01AM EST  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Mar 2, 2021
08:03AM EST  Morgan Stanley Maintains Overweight on Insmed, Raises Price Target to $58   Benzinga
Feb 25, 2021
08:25AM EST  Insmed Inc Q4 Net Loss $102.2 Mln Vs. Net Loss $53.0 Mln Last Year   RTTNews
08:19AM EST  Insmed Q4 EPS $(1.00) Misses $(0.70) Estimate, Sales $41.41M Miss $41.44M Estimate   Benzinga
08:08AM EST  The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants   Benzinga
07:31AM EST  Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides   PR Newswire
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 24, 2021
08:01AM EST  Insmed to Present at Two March Conferences   PR Newswire
Feb 19, 2021
08:38AM EST  Insmed's Inhaled Treprostinil Palmitil Is Safe; Healthy Volunteers Study Show   Benzinga
07:32AM EST  Insmed Announces Topline Results from Phase 1 Study Of Treprostinil Palmitil Inhalation Powder; Study Showed TPIP Was 'generally safe and well tolerated, with a pharmacokinetic profile that supports once-daily dosing'   Benzinga
07:32AM EST  Insmed Announces Topline Results From Phase 1 Study Of Treprostinil Palmitil Inhalation Powder   RTTNews
07:30AM EST  Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil   PR Newswire
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 16, 2021
08:01AM EST  Insmed to Host Conference Call to Discuss Topline Data from Treprostinil   PR Newswire
Feb 12, 2021
08:01AM EST  Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference   PR Newswire
Feb 5, 2021
08:01AM EST  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Jan 22, 2021
07:22AM EST  The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa   Benzinga
Jan 19, 2021
08:48AM EST  Credit Suisse Maintains Outperform on Insmed, Raises Price Target to $60   Benzinga
Jan 5, 2021
08:01AM EST  Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference   PR Newswire
Jan 4, 2021
08:55AM EST  Insmed Initiates Frontline Clinical Trial Program For ARIKAYCE In Patients With MAC Lung Disease   RTTNews
08:02AM EST  Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE(r) (amikacin   PR Newswire
07:16AM EST  10 Biggest Price Target Changes For Monday   Benzinga
04:37AM EST  SVB Leerink Maintains Outperform on Insmed, Raises Price Target to $55   Benzinga
Dec 17, 2020
10:17AM EST  Benzinga's Top Upgrades, Downgrades For December 17, 2020   Benzinga
09:54AM EST  Berenberg Initiates Coverage On Insmed with Buy Rating, Announces Price Target of $48   Benzinga
Dec 16, 2020
12:52PM EST  Morgan Stanley Maintains Overweight on Insmed, Raises Price Target to $55   Benzinga
Dec 15, 2020
07:52AM EST  The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding   Benzinga
Dec 4, 2020
08:01AM EST  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Dec 2, 2020
08:12AM EST  Insmed Initiates Phase 3 ASPEN Study Of Brensocatib In Patients With Bronchiectasis   RTTNews
08:02AM EST  Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients   PR Newswire
Nov 24, 2020
08:53AM EST  Evercore ISI Group Reinstates Outperform on Insmed, Announces $60 Price Target   Benzinga
08:01AM EST  Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference   PR Newswire
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 13, 2020
08:06AM EST  Insmed Receives Priority Medicines Designation From EMA For Brensocatib In Patients With NCFBE   RTTNews
08:01AM EST  Insmed Reports Receives Priority Medicines Designation From EMA For Brensocatib In Patients With Non-Cystic Fibrosis Bronchiectasis   Benzinga
08:01AM EST  Agency (EMA) for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)   PR Newswire
Nov 11, 2020
08:04AM EST  Morgan Stanley Maintains Overweight on Insmed, Raises Price Target to $42   Benzinga
Nov 6, 2020
08:01AM EST  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Nov 2, 2020
08:01AM EST  Insmed to Present at Two November Conferences   PR Newswire
Oct 29, 2020
07:55AM EDT  Insmed Q3 EPS $(0.63) Misses $(0.61) Estimate, Sales $43.60M Miss $46.07M Estimate   Benzinga
07:31AM EDT  Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update   PR Newswire
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 28, 2020
07:45AM EDT  Insmed Says European Commission Grants Marketing Authorization For ARIKAYCE Liposomal 590 Mg Nebuliser Dispersion   RTTNews
07:39AM EDT  Insmed Announces European Commission Grants Marketing Authorization For ARIKAYCE Liposomal 590 mg Nebuliser Dispersion For Treatment Of NTM Lung Infections Caused By MAC In Adult Non-CF Patients With Limited Treatment Options   Benzinga
07:38AM EDT  Insmed Reports European Commission Granted Marketing Authorization For ARIKAYCE Liposomal 590 mg Nebuliser Dispersion For Treatment Of Nontuberculous Mycobaterial Lung Infections   Benzinga
07:38AM EDT  590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Adult Non-CF Patients with Limited Treatment Options   PR Newswire
Oct 22, 2020
07:52AM EDT  The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat   Benzinga
Oct 21, 2020
08:04AM EDT  The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings   Benzinga
Oct 20, 2020
08:17AM EDT  The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger   Benzinga
08:01AM EDT  Insmed to Host Third Quarter 2020 Financial Results Conference Call on   PR Newswire
Oct 12, 2020
10:39AM EDT  Stifel Reinstates Buy on Insmed, Announces $44 Price Target   Benzinga
Oct 2, 2020
08:06AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   RTTNews
Sep 30, 2020
08:07AM EDT  Insmed Outlines Growth Strategy At R&D Day   Benzinga
08:02AM EDT  Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D   PR Newswire
Sep 16, 2020
08:01AM EDT  Insmed to Host R&D Day on September 30, 2020   PR Newswire
Sep 9, 2020
04:05PM EDT  Insmed to Present at Three September Conferences   PR Newswire
Sep 7, 2020
11:24AM EDT  New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW   PR Newswire
Sep 4, 2020
08:01AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   RTTNews
Aug 10, 2020
09:19AM EDT  Morgan Stanley Maintains Overweight on Insmed, Raises Price Target to $38   Benzinga
Aug 7, 2020
08:01AM EDT  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   PR Newswire
Aug 6, 2020
08:09AM EDT  Insmed Q2 EPS $(0.64) Misses $(0.63) Estimate, Sales $42.50M Beat $34.51M Estimate   Benzinga
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:43AM EDT  Insmed Q2 Net Loss $61.9 Mln Or $0.64/shr Vs. Net Loss $66.5 Mln Or $0.81/shr Last Year   RTTNews
07:31AM EDT  Insmed Reports Second Quarter 2020 Financial Results and Provides Business   PR Newswire
Jul 27, 2020
08:01AM EDT  Insmed to Host Second Quarter 2020 Financial Results Conference Call on   PR Newswire
Jul 24, 2020
10:00AM EDT  Insmed shares are trading higher after the company's lung infection treatment received a positive opinion from the European Medicines Agency.   Benzinga
07:55AM EDT  Insmed Receives Positive CHMP Opinion For ARIKAYCE Liposomal 590 Mg Nebuliser Dispersion   RTTNews
07:39AM EDT  Insmed Reports Receives Positive CHMP Opinion For ARIKAYCE Liposomal 590 mg Nebuliser Dispersion For Treatment Of NTM Lung Infections Caused By MAC In Non-CF Patients With Limited Treatment Options   Benzinga
07:37AM EDT  Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC